Technical Analysis for SGIOY - Shionogi & Co Ltd Un

Grade Last Price % Change Price Change
grade B 14.6599 -0.64% -0.0951
SGIOY closed down 0.64 percent on Wednesday, July 8, 2020, on 22 percent of normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical SGIOY trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Strong but Oversold Other 0.00%
Strong, Oversold and Reversal Signs Reversal 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Older signals for SGIOY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company primarily focuses on metabolic syndrome, pain, infectious diseases, cholesterol medication, anti-hypertension drugs, depression treatment, prescription drugs, OTC drugs, and diagnostics. Its primary products include Cymbalta, a serotonin and noradrenaline reuptake inhibitor used for the treatment of depression, anxiety, diabetic neuropathic pain, fibromyalgia pain, chronic lower back pain, and osteoarthritis pain; Intuniv, a selective a2 adrenergic receptor agonist to treat attention-deficit hyperactivity disorder; Xofluza, an anti-influenza agent; and Symproic, a cancer pain analgesic tablet. It has a research collaborative agreement with National University Corporation Kyoto University to focus on drug discovery and medical research for the treatment of psychiatric disorders; strategic collaboration with Sage Therapeutics, Inc. to develop and commercialize SAGE-217 for MDD and other indications; license and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics Inc.; a strategic collaboration with Tetra Discovery Partners LLC for the clinical development and commercialization of BPN14770, a selective phosphodiesterase-4D allosteric inhibitor; and a collaborative research agreement with PeptiDream Inc. for the discovery and development of a series of blood brain barrier penetrating peptide drug-conjugates. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Chemistry RTT Cancer Pharmaceuticals Drugs Pain Infectious Diseases Chemical Compounds Drug Discovery Osteoarthritis Depression Fibromyalgia Attention Deficit Hyperactivity Disorder Back Pain Psychiatric Disorders Treatment Of Depression Kyoto University Metabolic Syndrome Depression Treatment Duloxetine Mycobacterial Diseases Naldemedine National University Corporation Kyoto University Shionogi Symproic Treatment Of Mycobacterial Diseases Treatment Of Psychiatric Disorders

Is SGIOY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 16.89
52 Week Low 9.24
Average Volume 157,010
200-Day Moving Average 14.1622
50-Day Moving Average 14.5814
20-Day Moving Average 15.6271
10-Day Moving Average 15.4785
Average True Range 0.4727
ADX 21.07
+DI 21.8745
-DI 31.5222
Chandelier Exit (Long, 3 ATRs ) 15.4719
Chandelier Exit (Short, 3 ATRs ) 15.9081
Upper Bollinger Band 16.7174
Lower Bollinger Band 14.5368
Percent B (%b) 0.06
BandWidth 13.9540
MACD Line 0.1430
MACD Signal Line 0.3737
MACD Histogram -0.2307
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.9299
Resistance 3 (R3) 14.9033 14.7866 14.8849
Resistance 2 (R2) 14.7866 14.7179 14.8000 14.8699
Resistance 1 (R1) 14.7233 14.6754 14.6650 14.7499 14.8549
Pivot Point 14.6066 14.6066 14.5775 14.6200 14.6066
Support 1 (S1) 14.5433 14.5379 14.4850 14.5699 14.4649
Support 2 (S2) 14.4266 14.4954 14.4400 14.4499
Support 3 (S3) 14.3633 14.4266 14.4349
Support 4 (S4) 14.3899